Picture of Zhongzhi Pharmaceutical Holdings logo

3737 Zhongzhi Pharmaceutical Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for Zhongzhi Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line16761.8131208147
Depreciation
Amortisation
Non-Cash Items-20.129.8-11.3-17.34.34
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1541.7168.8-190-79.8
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities93.2178285102181
Capital Expenditures-126-188-89.1-171-142
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-12451.9103-31.321.8
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-250-13613.4-203-120
Financing Cash Flow Items1.50.60.020.485-0.732
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-71.9-40.8-68.1-155-58.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2292.35228-2572.73